Operating procedure

Individual sample inspection is available to avoid unnecessary queueing time for other samples.

The result of the sample analysis is obtained within 1 hour. Handling the sample and operating the device are simple and easy to master.

Kit

Using our integrated microfluidic technology and detection kits, simultaneous detection of influenza A, B, and new coronaviruses is achieved with a single sample loading at a high degree of precision and with internal reference in each assay setup.

More test kits will be available in the future.

Application areas

Our technology is suitable for the detection of nucleic acids in various environments, such as quarantine institutions, primary medical units, flow quarantine sites, scientific institutes, and enterprise laboratories.

Platform advantages

Small and light

The instrument is small, light and easily portable. It can thus be used flexibly and saves laboratory space.

Rapid detection

The single sample detection cycle is short. Detection is completed within 1 hour, thus reducing waiting time.

Supporting extended access

Analysis can be extended to 1-12 channels, thus allowing for diversified detection.

Easy handling

The detection step is simple and easy and does not require nucleic acid extraction.

Contamination prevention

Detection takes place in an integrated airtight chip kit,thus removing the risk of cross-contamination between the samples.

On patents and trademark of LAMP(R) technology:
LAMP®, (Loop-mediated Isothermal Amplification) nucleic acid amplification and detection technology is patented by and also a trademark of Eiken Chemical Co., Ltd.（CN1420928A/CN1222614C）.
Please contact Eiken China Co., Ltd. for patent and trademark licensing on commercialization of LAMP(R) technology.